CLINICAL_TRIALS
trial_result
· 2020-04-14
Clinical Trial Update: Reversal Dabigatran Anticoagulant Effect With Idarucizumab [Phase 3]
Summary
Phase 3 trial updating on reversing dabigatran anticoagulant effect with idarucizumab in hemorrhage setting; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Hemorrhage | Phase 3 | Status: COMPLETED | Results posted: 2020-04-14